2 completed, 2 terminated. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow tezosentan: new trials by email Literature Review of tezosentan trials Research Report on tezosentan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tezosentan in Pulmonary Arterial Hypertension Tezosentan - Pulmonary Arterial Hypertension | Phase 2 | Terminated | Idorsia Pharmaceuticals Ltd. | 3 | 2010-08-01 | 2018-07-09 |
| Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery tezosentan, placebo - Heart Diseases, Hypertension, Pulmonary | Phase 3 | Terminated | Idorsia Pharmaceuticals Ltd. | 274 | 2007-04-01 | 2018-07-09 |
| Tezosentan in the Treatment of Acute Heart Failure tezosentan, placebo - Acute Heart Failure, Acute Decompensation of Chronic Heart Failure | Phase 3 | Completed | Idorsia Pharmaceuticals Ltd. | 713 | 2003-04-01 | 2018-07-10 |
| Tezosentan in Acute Heart Failure tezosentan - Acute Heart Failure, Acute Decompensation of Chronic Heart Failure | Phase 3 | Completed | Idorsia Pharmaceuticals Ltd. | 735 | 2003-04-01 | 2018-07-10 |
Heart Diseases (1) · Heart Failure (1) · Hypertension, Pulmonary (1) · Pulmonary Arterial Hypertension (1)
Idorsia Pharmaceuticals Ltd. (4)
United States (4) · France (3) · Germany (3) · United Kingdom (3) · Austria (2) · Czechia (2) · Israel (2) · Italy (2) · Poland (2) · Switzerland (2) · Australia (1) · Canada (1) · Denmark (1) · Greece (1) · Hungary (1)
Andre Denault, Prof. (1) · Andrea D'Armini, Prof. (1) · Elisabet Lindberg, MD (1) · Rainald Seitelberger, Prof. (1) · Robert Michler, MD (1) · Ronald Pearl, MD (1) · Steven Tsui (1)